Lamotrigine Tablet
Product Images NDC 72789-206

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 72789-206). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789206 Label (72789206)

The image shows a dual-language label for Lamotrigine USP 100 mg tablets, packaged in 60-count bottles. It includes the labeler PD-Rx Pharmaceuticals, Inc., located in Oklahoma City, OK, the NDC 72789-206-60, and batch details including lot C22F08 and expiration date 05/2023. It features dosing instructions in English and Spanish alongside a warning to keep out of children's reach.*

FDA Label Image

Molecular Structure (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 01)

Chemical structure of lamotrigine, illustrating its aromatic ring with two chlorine atoms and the triazine ring system attached to amine groups.*

FDA Label Image

Figure 1 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 02)

A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over a timeline of weeks up to 100. The vertical axis shows failure probability in percent, and the horizontal axis shows time in weeks. The graph includes censored data points marked with crosses.*

FDA Label Image

Figure 2 (Ad7af627 Ea4b 4a78 A71e Db1255416d1e 03)

A Kaplan-Meier failure probability graph depicting failure probability (%) over weeks for Lamotrigine and Placebo groups. The graph includes censored data markers and shows the progression of failure probability up to approximately 80 weeks, with separate step curves for Lamotrigine and Placebo treatments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.